Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityNo recent work listed

Bang-li Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4401-0601; OpenAlex author ID A5017884739. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 3 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 5

  1. Hypoxia-Related Signature Is a Prognostic Biomarker of Pancreatic Cancer. Last author DOI 10.1155/2022/6449997↗
  2. Targeted blockade of interleukin 9 inhibits tumor growth in murine model of pancreatic cancer. Co-author DOI 10.17219/acem/104543↗
  3. Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis. Co-author DOI 10.1097/md.0000000000008261↗
  4. Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis. Co-author DOI 10.1155/2017/2831056↗
  5. [Interleukin-9 promotes pancreatic cancer cell proliferation and migration via activation of STAT3 pathway]. Last author PMID 29089082↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shanyu Qin · 4 shared papers, 2017–2019 · strength 0.39
  2. Qiulan Huang · 2 shared papers, 2017 · strength 0.17
  3. Jingjing Zhang · 1 shared paper, 2022 · strength 0.16
  4. Dongcheng Lu · 1 shared paper, 2019 · strength 0.12
  5. Haixing Jiang · 1 shared paper, 2017 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.